Sortilin as a Novel Diagnostic and Therapeutic Biomarker in Chronic Lymphocytic Leukemia

BACKGROUND: The overexpression of sortilin/neurotensin receptor 3 has previously been reported in various human solid tumors but not in hematological malignancies. Here, we report the overexpression of sortilin in leukemic cells from patients with Chronic Lymphocytic Leukemia (CLL). METHODS: Flow cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Farahi, Lia, Ghaemimanesh, Fatemeh, Milani, Saeideh, Razavi, Seyed Mohsen, Akhondi, Mohammad Mehdi, Rabbani, Hodjattallah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925395/
https://www.ncbi.nlm.nih.gov/pubmed/31908734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925395/
https://www.ncbi.nlm.nih.gov/pubmed/31908734

Ejemplares similares